Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/24/2025

Drug Interactions with Sacubitril/Valsartan

Introduction to Sacubitril/Valsartan Interactions

  • The American College of Cardiology recommends that sacubitril/valsartan has clinically significant interactions primarily with ACE inhibitors, aliskiren, and statins, while also requiring careful monitoring when combined with potassium-sparing agents, NSAIDs, and lithium 1, 2

Absolute Contraindications

  • The American College of Cardiology states that ACE inhibitors are absolutely contraindicated with sacubitril/valsartan, requiring a mandatory 36-hour washout period before initiating sacubitril/valsartan to prevent life-threatening angioedema 1, 2
  • Aliskiren is contraindicated in patients with diabetes, and should be avoided in patients with eGFR <60 mL/min/1.73 m² 1

Statin Interactions Requiring Dose Adjustment

  • The American Heart Association notes that coadministration of sacubitril/valsartan with atorvastatin increased atorvastatin Cmax up to 2-fold and AUC by up to 1.3-fold, though no significant adverse events were reported 3, 4
  • Lower doses of atorvastatin, fluvastatin, pitavastatin, pravastatin, rosuvastatin, or simvastatin may be considered when used in combination with sacubitril/valsartan 3, 4

Monitoring Strategy for Drug Interactions

  • The American College of Cardiology recommends blood pressure monitoring, as sacubitril/valsartan may exert more pronounced BP effects than ACE inhibitors/ARBs alone 2
  • Renal function (serum creatinine, eGFR) should be monitored routinely, especially with aldosterone antagonists or NSAIDs 5
  • Serum potassium requires serial measurement, particularly with MRAs or potassium-sparing diuretics 5

Special Populations and Interaction Considerations

  • The American College of Cardiology states that severe renal impairment (eGFR <30 mL/min/1.73 m²) requires reduced starting dose of 24/26 mg twice daily 1, 2

Common Pitfalls to Avoid

  • The American College of Cardiology warns to never initiate sacubitril/valsartan within 36 hours of the last ACE inhibitor dose to prevent angioedema 1, 2